Koenig, K FK FKoenigRibi, CCRibiRadosavac, MMRadosavacZulewski, HHZulewskiTrendelenburg, MMTrendelenburgHuynh-Do, UyenUyenHuynh-Do0000-0002-7276-032X2024-10-232024-10-232015-01https://boris-portal.unibe.ch/handle/20.500.12422/132667OBJECTIVES Systemic lupus erythematosus (SLE) is associated with considerable cardiovascular morbidity that has not yet been directly compared with other diseases with known cardiovascular risk. METHODS Two hundred and forty-one patients of the multicentre Swiss SLE cohort study (SSCS) were cross-sectionally assessed for coronary heart disease (CHD), cerebrovascular disease (CVD) and peripheral artery disease (PAD). SLE patients were compared with a cohort of 193 patients with type-1 diabetes mellitus being followed at the University Hospital Basel. A subgroup analysis of 50 age- and sex-matched patients from the University Hospital Basel was performed. RESULTS Of patients within the SSCS 13.3% had one or more vascular events: 8.3% CHD, 5% CVD and 1.2% PAD. In type-1 diabetes mellitus patients, 15% had vascular events: 9.3% CHD, 3.1% CVD and 5.6% PAD. In the matched subgroup, 26% of SLE patients had vascular events (14% CHD) compared with 12% in type-1 DM patients (2% CHD). Cardiovascular risk factors were similar in both groups. Vascular events in SLE patients were associated with age, longer disease duration, dyslipidaemia, and hypertension. CONCLUSION Cardiovascular morbidity in SLE is at least as frequent as in age- and sex-matched type-1 diabetes mellitus patients. Therefore, aggressive screening and management of cardiovascular risk factors should be performed.enSystemic lupus erythematosuscardiovascular eventsnon-traditional cardiovascular risk factorstype-1 diabetes mellitus600 - Technology::610 - Medicine & healtharticle10.7892/boris.677922518216910.1177/0961203314550223